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Xenopus oocytes exhibit both pertussis toxin-sensitive
and -insensitive inositol lipid signaling responses to G
protein-coupled receptor activation. The G protein sub-
units Gai, Gao, Gaq, Gas, and Gbg all have been proposed
to function as activators of phospholipase C in oocytes.
Ma et al. (Ma, H.-W., Blitzer, R. D., Healy, E. C., Premont, R.
T., Landau, E. M., and Iyengar, R. J. Biol. Chem. 268,
19915–19918) cloned a Xenopus phospholipase C (PLC-bX)
that exhibits homology to the PLC-b class of isoenzymes.
Although this enzyme was proposed to function as a sig-
naling protein in the pertussis toxin-sensitive inositol
lipid signaling pathway of oocytes, its regulation by G
protein subunits has not been directly assessed. As such
we have utilized baculovirus-promoted overexpression of
PLC-bX in Sf9 insect cells and have purified a recombi-
nant 150-kDa isoenzyme. PLC-bX catalyzes hydrolysis of
phosphatidylinositol(4,5)bisphosphate and phosphati-
dylinositol(4)monophosphate, and reaction velocity is de-
pendent on Ca21. Recombinant PLC-bX was activated by
both Gaq and Gbg. PLC-bX exhibited a higher apparent
affinity for Gaq than Gbg, and Gaq was more efficacious
than Gbg at lower concentrations of PLC-bX. Relative to
other PLC-b isoenzymes, PLC-bX was less sensitive to
stimulation by Gaq than PLC-b1 but similar to PLC-b2
and PLC-bT. PLC-bXwasmore sensitive to stimulation by
Gbg than PLC-b1 but less sensitive than PLC-b2 and PLC-
bT. In contrast PLC-bXwas not activated by the pertussis
toxin substrate G proteins Gai1, Gai2, Gai3, or Gao. These
results are consistent with the idea that PLC-bX is regu-
lated by a-subunits of the Gq family and by Gbg and do not
support the idea that a-subunits of pertussis toxin-sensi-
tive G proteins are directly involved in regulation of this
protein.
Xenopus oocytes have been used broadly to define the phar-
macological and signaling selectivities of cloned, expressed G
protein1-coupled receptors. Oocytes exhibit a Ca21-activated
Cl2 current (ICa-Cl) whose mean peak current correlates with
intracellular inositol(1,4,5)trisphosphate concentrations (1)
and which has been utilized as a convenient, real-time readout
of PLC stimulation by heterologously expressed receptors.
PLC-activating receptors expressed in Xenopus oocytes do not
always maintain a fidelity of coupling to pertussis toxin (PTX)-
insensitive G proteins, i.e. Gq family G proteins, usually asso-
ciated with activation of these receptors in mammalian cells.
For example, inositol lipid hydrolysis promoted by the
[Arg8]vasopressin (2), 5-HT1c serotonin (3), m1 muscarinic (4),
or a1b-adrenergic (4) receptors exhibit a sensitivity to blockade
by PTX in oocytes that is absent in mammalian cells. However,
a PTX-insensitive PLC response also exists in Xenopus oocytes
and can be activated by heterologously expressed m1 musca-
rinic (5) or mGluR1 metabotropic glutamate (6) receptors.
The G protein activator(s) of Xenopus oocyte PLC has not
been unambiguously defined. Xenopus Gai1, Gai3, Gao, Gas (7,
8), Gaq, and Ga11 (9) are 75–89% identical to their mammalian
homologues, suggesting a similar functionality of these well
conserved proteins. Moriarty et al. (10) reported that the en-
dogenous muscarinic receptor of Xenopus oocytes was coupled
to a PTX-sensitive ICa-Cl response that could be stimulated by
Gao but not Gai. Gao also has been implicated in the PTX-
sensitive inositol lipid signaling pathway associated with sev-
eral other receptors exogenously expressed in Xenopus oocytes,
including mGluR1, mGluR5 (11), 5-HT1c (4, 12), m1 muscarinic
(10, 13), and a1B-adrenergic (4) receptors. Others have reported
that Gai mediates the oocyte inositol lipid signaling response to
m1 muscarinic (3, 11), m-opioid, k-opioid (14), and d-opioid (15)
receptors. Gaq (16), Ga11 (6), and Gas (12) have been proposed
to mediate PTX-insensitive activation of PLC by G protein-
coupled receptors in oocytes.
Clapham and co-workers (5) recently suggested that PTX-
insensitive activation of PLC in Xenopus oocytes is not trans-
duced by Gaq subunits, but rather involves Gbg released from
the Gq heterotrimer. ICa-Cl was activated by injection of purified
Gbg and agents that bound free Gbg also blocked activation of
ICa-Cl by m3 muscarinic receptors. Although this finding sug-
gests a role for Gbg in activation of PLC, other groups observed
no effect of purified Gbg on ICa-Cl in oocytes (17, 18).
In face of the conflicting reports of G protein subunit-medi-
ated regulation of inositol lipid signaling in Xenopus oocytes, it
is important to identify and to define directly the regulation of
the involved Xenopus PLC. Iyengar and co-workers (18) cloned
a frog PLC (PLC-bX) that shares high homology with previ-
ously identified mammalian and Drosophila PLC-b isoen-
zymes. The highest percent identity was with mammalian
PLC-b3, which has been shown to be activated by both Gaq and
Gbg (19). Injection of oocytes with antisense oligonucleotides to
block expression of PLC-bX reduced the PTX-sensitive ICa-Cl
response to endogenous angiotensin receptors and to heterolo-
gously expressed a1-adrenergic and m1 muscarinic acetylcho-
line receptors. These results, together with previous studies
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illustrating Gai- and Gao-promoted activation of ICa-Cl, led to
the suggestion that PLC-bX is activated by a-subunits of the
pertussis toxin-sensitive class of G proteins. To directly address
the regulation of PLC-bX by G protein subunits, we have pu-
rified recombinant isoenzyme for the first time following bacu-
lovirus-mediated expression in Sf9 cells. This 150-kDa protein
is Ca21-sensitive, selectively catalyzes the hydrolysis of
PtdIns(4)P and PtdIns(4,5)P2, and is activated by both Gaq and
Gbg. Importantly, we observed no evidence for activation of
PLC-bX by either Gao or Gai subunits.
EXPERIMENTAL PROCEDURES
Materials—PtdIns(4)P and PtdIns(4,5)P2 were purified from bovine
brain Folch fraction I (Sigma) as described previously (20). [3H]PtdIns,
[3H]PtdIns(4)P, and [3H]PtdIns(4,5)P2 were purified as described pre-
viously (21) from turkey erythrocytes labeled with [3H]inositol.
PLC-bX cDNA was provided by Dr. Ravi Iyengar (Mt. Sinai Medical
Center). Gbg purified from bovine brain was a generous gift from Dr.
Patrick Casey (Duke University). Gb1g2 subunits purified following
overexpression in Sf9 cells as well as baculoviruses encoding Gb2, Gg2,
and C-terminal hexahistidine-tagged Gaq were kindly provided by Drs.
John Hepler and Alfred Gilman (University of Texas Southwestern
Health Sciences Center). Recombinant Gai1, Gai2, and Gai3, purified
from Sf9 cell cytosol following overexpression, were kindly provided by
Dr. James Garrison (University of Virginia).
Recombinant, myristoylated Gao subunits were purchased from Cal-
biochem. Phosphatidylcholine (brain), phosphatidylserine (bovine
brain), phosphatidylethanolamine (bovine heart), and PtdIns (bovine
liver) were purchased from Avanti Polar Lipids (Alabaster, AL). BSA
and fatty acid free BSA (fraction V), benzamidine, phenylmethylsulfo-
nyl fluoride, and Tween 20 were purchased from Sigma. Pepstatin A
was purchased from Peptides International (Louisville, KY). Hydroxyl-
apatite (Bio-Gel HTP), acrylamide, bisacrylamide, Tris, glycine, nitro-
cellulose, TEMED, ammonium persulfate, SDS, 5-bromo-4-chloro-3-in-
dolyl phosphate, and nitro blue tetrazolium chloride were acquired from
Bio-Rad. Excell 401 medium and Grace’s insect culture medium were
purchased from JRH Biosciences (Lenexa, KS). Fetal bovine serum was
from Irvine Scientific (Santa Ana, CA). Alkaline phosphatase-conju-
gated goat anti-rabbit IgG antiserum, NotI, ClaI, and XbaI were pur-
chased from Boehringer Mannheim. Baculogold viral DNA transfection
kit and pVL1392 vector were purchased from PharMingen (San Diego,
CA). Mono Q HR 5/5 column, Q-Sepharose, and heparin-Sepharose
resins were purchased from Pharmacia Biotech Inc. Nickel-nitrilotri-
acetic acid resin was bought from Qiagen (Chatsworth, CA). Sf9 insect
cells (ATCC CRL1711) were purchased from Invitrogen (San Diego,
CA).
Production and Purification of Recombinant PLC-bX
Baculovirus—cDNA sequence for PLC-bX was subcloned into pVL1392,
a baculovirus-compatible transfection vector, in two fragments. A 1636-
base pair NotI-ClaI fragment and a 3023-base pair ClaI-XbaI fragment
of PLC-bX were ligated into pVL1392 linearized with NotI and XbaI.
The resulting 14.3-kilobase pair plasmid (pVL1392-PLC-bX) was se-
quenced at the vector/PLC-bX junction sites to confirm complete inser-
tion. PLC-bX recombinant baculovirus was constructed by co-transfec-
tion of pVL1392-PLC-bX with Baculogold viral DNA into Sf9 cells using
the Baculogold transfection kit. Recombinant virus was isolated and
purified through three rounds of plaque assay by standard procedures
(22).
Sf9 Cell Culture—Sf9 insect cells were maintained as suspension
cultures in spinner flasks (70 rpm) at 27 °C in Grace’s insect medium
supplemented with 10% fetal bovine serum, 3.3 g/liter yeastolate, 3.3
g/liter lactalbumin, 6.4 mM glutamine, and antibiotic/antimycotic mix.
Large Scale Infection and Expression of PLC-bX—Sf9 cells were
serum-free-adapted by transfer into Excell 401 medium supplemented
with antibiotic/antimycotic in a 1L Bellco stir flask, and the propeller
speed was increased to 120 rpm for 400 ml of cell culture. After attain-
ing a doubling rate of 24 h, Sf9 cells were infected at a density of 2–3 3
106 cells/ml using a viral multiplicity of infection of 3. Sf9 cells were
collected by low speed centrifugation (500 3 g, 5 min, 4 °C) 48 h after
infection and were washed once with low pH PBS (140 mM NaCl, 40 mM
KCl, 1 mM Na2HPO4, 10.5 mM KH2PO4, pH 6.2). The resultant cell
pellet was resuspended at 2 3 107 cells/ml in hypotonic lysis buffer
consisting of 20 mM Hepes, pH 7.4, 5 mM MgCl2, 2 mM EGTA, and
protease inhibitor mixture (200 mM phenylmethylsulfonyl fluoride, 200
mM benzamidine, and 2 mM pepstatin A) and incubated 10 min on ice
prior to Dounce homogenization (10 strokes). Following low speed cen-
trifugation (500 3 g, 5 min, 4 °C) the supernatant was cleared by
ultracentrifugation (100,000 3 g, 60 min, 4 °C) and the resultant cy-
tosol frozen at 280 °C. Cytosol from a total of 1.3 3 1010 infected Sf9
cells was collected prior to purification.
Purification of PLC-bX—A 100-ml Q-Sepharose FF column (2.6 3 20
cm) was equilibrated with buffer A (25 mM Hepes, pH 7.2, 2 mM
dithiothreitol, 2 mM EDTA, 2 mM EGTA, and protease inhibitor mix-
ture) containing 10 mM NaCl. Sf9 cytosol (670 ml mixed 1:1 with buffer
A) was applied at a flow rate of 14 ml/min. The column was washed with
2 column volumes of buffer A plus 10 mM NaCl, and protein was eluted
with a 10-column volume linear gradient of 10–600 mM NaCl in buffer
A. Fifteen-ml column fractions were collected and 2 ml of every other
fraction was assayed for PLC activity using cholate-containing
[3H]PtdIns(4)P vesicles. Fractions containing PLC activity (fractions
19–33; 225 ml; 170–300 mM NaCl eluate) were pooled, diluted into 2
volumes of buffer B (25 mM Hepes, pH 7.2, 10 mM KCl, 2 mM dithio-
threitol, and protease inhibitor mixture) containing 5 mM KH2PO4, and
applied to a 50-ml hydroxylapatite column (2.6 3 10 cm) at a rate of 4
ml/min. The hydroxylapatite column was washed with 2 column vol-
umes of buffer B plus 10 mM KH2PO4, and protein was eluted with a
12-column volume linear gradient of 10–600 mM potassium phosphate
(168 mM KH2PO4, 432 mM K2HPO4, pH 7.2) in buffer B. Aliquots (0.5 ml)
of every other fraction were assayed for PLC activity, and the fractions
containing PLC activity (fractions 57–76; 150 ml; 410–540 mM phos-
phate eluate) were pooled and diluted in 2 volumes of buffer A. A 14-ml
column of heparin-Sepharose CL-6B (1.6 3 7 cm) was equilibrated in
buffer A plus 10 mM NaCl, and the pooled PLC-containing sample was
applied to the column at a rate of 3 ml/min. Protein was eluted with a
280-ml linear gradient of 10–1000 mM NaCl in buffer A. Four-ml
fractions were collected and 0.1 ml assayed for PLC activity. As a final
concentrating step, fractions containing PLC activity (fractions 38–52;
60 ml; 500–760 mM NaCl eluate) were pooled, diluted in 6 volumes of
buffer C (buffer A containing 20% glycerol), and applied to an FPLC
Mono Q HR 5/5 column pre-equilibrated in buffer C plus 10 mM NaCl.
Proteins were eluted with a 25-ml gradient of 10–1000 mM NaCl in
buffer C. Fractions (0.5 ml) containing PLC activity (13–15) were pooled
and stored as aliquots at 280 °C. PLC-bX concentration was deter-
mined by comparison with a standard protein curve on a silver-stained
7.5% SDS-PAGE gel.
Purification of Turkey and Mammalian PLC-b Isoenzymes—PLC-bT
(23), PLC-b1 (24), and PLC-b2 (24) were purified to homogeneity from
Sf9 cells following baculovirus-mediated expression as described
previously.
Purification of GaqHis6—C-terminal hexahistidine-tagged Gaq was
expressed from recombinant baculovirus and purified over a nickel-
nitrilotriacetic acid column from membranes collected from Sf9 cells as
described by Hepler et al. (25).
Phospholipase C Assay—Catalytic activity of PLC-bX was quanti-
tated with [3H]PtdIns(4)P or [3H]PtdIns(4,5)P2 as described previously
(21). PLC (25 ml; 1–10 ng) in 10 mM Hepes, pH 7.0, and 2 mg/ml fatty
acid-free BSA was added to 75 ml of reaction mixture on ice to give these
final concentrations of the following components: 50 mM phospholipid
(except when varied for kinetic analysis), 15,000 cpm [3H]phospholipid,
0.5% (w/v) sodium cholate, 10 mM Hepes, pH 7.4, 120 mM KCl, 10 mM
NaCl, 2 mM EGTA, 5.8 mM MgSO4, and 2.1 mM CaCl2 (unless otherwise
indicated). Incubations were for 5 min at 30 °C and were terminated by
addition of 375 ml of CHCl3:CH3OH:HCl (40:80:1). CHCl3 (125 ml) and
0.1 N HCl (125 ml) were added, the samples mixed vigorously, and
aqueous and organic phases separated by centrifugation for 5 min at
2000 3 g. [3H]Product release was quantitated by scintillation counting
of 400 ml of the upper phase.
Reconstitution Assay—Regulation of PLC-b activity was quantitated
utilizing detergent-free phospholipid vesicles reconstituted with puri-
fied PLC isoenzymes and G protein subunits. PtdIns(4)P (2 nmol),
phosphatidylserine (2 nmol), phosphatidylethanolamine (8 nmol), and
[3H]PtdIns(4)P (15,000 cpm) were dried under nitrogen and resus-
pended in dialysis buffer (20 mM Hepes, pH 7.4, 1 mM MgCl2, 2 mM
dithiothreitol, 100 mM NaCl, and protease inhibitor mixture) plus 0.8%
sodium cholate. G protein subunits (0.04–100 ng) were diluted in dial-
ysis buffer plus 0.8% sodium cholate and mixed 1:1 (v:v) with resus-
pended phospholipids. The G protein/phospholipid mixture was dia-
lyzed overnight against 2 liters of dialysis buffer (4 °C, in the dark), and
25 ml of the resultant unilamellar phospholipid vesicles were mixed
with 25 ml of 4 3 buffer (150 mM Hepes, pH 7.0, 300 mM NaCl, 16 mM
MgCl2, 8 mM EGTA, 6.4 mM CaCl2, and 1.6 mg/ml BSA (fatty acid-free)),
25 ml of PLC-bX (0.3–300 ng diluted in 20 mM Hepes, pH 7.0, plus 0.4
mg/ml BSA (fatty acid-free)), and with 25 ml of Hepes (20 mM Hepes, pH
7.0), or in the case of reconstitution with Ga, with 4 3 AlF4
2 (80 mM
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AlCl3, 40 mM NaF diluted in 20 mM Hepes, pH 7.0). Assays were
incubated at 30 °C for 5 min to maintain initial rate conditions in all
experiments. The reactions were terminated, and phospholipase C ac-
tivity was quantitated as described above.
GTPgS-stimulated activity was assessed after preincubation of Ga-
reconstituted vesicles for 1 h at 30 °C with 1 mM GTPgS. GTPgS (4 mM
in 20 mM Hepes, pH 7.0) was included in lieu of 4 3 AlF4
2 in these
assays.
PLC activity data are shown minus basal activities (1.72–15.6 mmol/
min/mg of protein) measured in the absence of G protein subunits. All
assays were performed in duplicate with the number of repetitions
indicated below each figure. Assays utilizing Gbg purified from bovine
brain were repeated with recombinant Gb1g2 purified from Sf9 cells, and
no difference in relative activity between subunit preparations was
detectable.
Electrophoresis, Silver Staining, and Immunoblotting—SDS-PAGE
(7.5% gels) was carried out according to the method of Laemmli (26).
Silver staining of gels was performed according to the method of Mor-
risey et al. (27). Following SDS-PAGE proteins were electrophoretically
transferred to nitrocellulose and PLC-bX protein immunologically de-
tected by antipeptide polyclonal antibody 1978 directed against a 12-
amino acid epitope from PLC-b3 (FINQKQRDPRLN) that shares 11 of
12 amino acids with PLC-bX. In brief, nitrocellulose was blocked in TBS
(20 mM Tris, pH 7.5, 500 mM NaCl) containing 3% BSA and incubated
overnight with a 1:500 dilution of antibody 1978 in TBS plus 1% BSA.
The nitrocellulose was washed with TBS plus 0.05% Tween 20 and
incubated for 1 h with alkaline phosphatase-conjugated goat-anti rabbit
IgG antibody (1:1000 dilution) in TBS plus 1% BSA. Proteins were
detected by incubation with alkaline phosphatase colorimetric sub-
strates (5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazo-
lium chloride).
RESULTS
Characterization of Purified Recombinant PLC-bX—The cod-
ing sequence for PLC-bX plus 12 base pairs of 59-untranslated
sequence preceded by a NotI restriction endonuclease site was
ligated into pVL1392, a baculovirus transfer vector containing
the polyhedron promoter for overexpression in Sf9 cells. Re-
combinant baculovirus encoding PLC-bX was obtained follow-
ing co-transfection of pVL1392-PLC-bX with Baculogold viral
DNA and was purified through three rounds of plaque assay
prior to large scale viral amplification. PtdIns(4)P-hydrolyzing
activity was detectable in lysates from Sf9 cells infected with
recombinant baculovirus, and active PLC-bX was purified to
near-homogeneity from cytosol prepared from these cells. Chro-
matography over a hydroxylapatite column provided the most
effective purification step.
A protein of approximately 150 kDa co-purified with PLC
activity (Fig. 1A), which coincides with the deduced mass of
PLC-bX of 139 kDa based on primary amino acid sequence. A
final yield of 500 mg of purified 150-kDa protein was obtained
from 1.3 3 1010 Sf9 cells. The purified protein preparation also
contained a .240-kDa species. Only the 150-kDa species was
detected by antibody 1978 (directed against a homologous
epitope in PLC-b3 and PLC-bX), which suggests that the high
molecular weight species is a contaminant rather than a mul-
timer of PLC-bX (Fig. 1B).
The dependence of purified PLC-bX on calcium and sub-
strate concentration was studied in catalytic assays in the
presence of 0.5% cholate. PLC-bX reaction velocity was depend-
ent on Ca21 concentration with a half-maximal rate observed
at 0.2 mM Ca21 and maximal rate obtained at 2–10 mM Ca21
(Fig. 2A). Reaction velocity also increased as a hyperbolic func-
tion of PtdIns(4,5)P2 concentration (Fig. 2B). A Hanes replot of
substrate concentration versus substrate concentration/reac-
tion velocity (Fig. 2B, inset) suggested a single enzymatic com-
ponent (r 5 0.91) with an apparent Vmax of 259 mmol/min/mg of
enzyme and an apparent Km for PtdIns(4,5)P2 of 216 mM.
PLC-bX also hydrolyzed PtdIns(4)P with reaction velocity de-
pendent on substrate concentration (data not shown). As has
been observed with mammalian PLC-b isoenzymes, PLC-bX
was selective for PtdIns(4)P and PtdIns(4,5)P2 over PtdIns,
catalyzing the hydrolysis of PtdIns only at high concentrations
of phospholipid (.300 mM) that precluded achievement of sat-
uration with respect to reaction velocity (data not shown).
PLC-bX was inactive against phosphatidylcholine under the
same assay conditions (data not shown).
Regulation of PLC-bX by Gaq—Hexahistidine-tagged recom-
binant Gaq was purified from Sf9 cell membranes as described
above. The hexahistidine tag on the C terminus has been
shown previously to not affect the regulatory activity of Gaq at
mammalian PLC-b isoenzymes (25). Gaq did not activate
PLC-bX in the absence of AlF4
2 (data not shown). However, in
the presence of AlF4
2, Gaq stimulated PLC-bX in a manner
FIG. 1. Purified PLC-bX. PLC-bX (200 ng) purified as described was
analyzed by electrophoresis on 7.5% SDS-PAGE. The gels were silver-
stained (A) or transferred to nitrocellulose and incubated with antibody
1978 produced against the peptide FINQKQRDPRLN, a sequence of
high homology in PLC-b isoenzymes. Antibody binding was detected by
alkaline-phosphatase-conjugated anti-IgG and colorimetric AP sub-
strate (B). Migration of molecular mass standards (kilodaltons) was as
indicated.
FIG. 2. Calcium and substrate dependence of PLC-bX catalytic
activity. Purified PLC-bX (5 ng) was incubated with the indicated
concentrations of Ca21 in an assay containing 0.5% cholate and 50 mM
PtdIns(4,5)P2 (A) or with the indicated concentrations of PtdIns(4,5)
P2 in an assay containing 0.5% cholate and 0.5 mM free calcium
(B). Each assay was incubated for 5 min at 30 °C and
[3H]inositol(1,4,5)trisphosphate quantitated as described. A replot of
the data by the method of Hanes is included as an inset. Vmax and Km
values for PtdIns(4,5)P2 were 259 mmol/min/mg and 216 mM, respec-
tively. The results are representative of three similar experiments.
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dependent on the concentration of G protein subunit and PLC
isoenzyme (Fig. 3A). Gaq activation of PLC-bX was detectable
at PLC concentrations of 1–10 ng/assay (67–670 pM) using
0.1–1 nM Gaq. At equimolar PLC enzyme concentrations,
PLC-b1 was stimulated by lower concentrations of Gaq than
PLC-bX, PLC-b2, and PLC-bT (Fig. 3B).
Regulation of PLC-bX by Gbg—Bovine brain Gbg activated
PLC-bX in a manner dependent on the concentration of G
protein subunit and PLC-bX (Fig. 4A). Marked activation by
1–10 nM Gbg required 30–300 ng/assay (2–20 nM) of PLC-bX.
This represents an approximately 30-fold increase in PLC-bX
concentration and a 10-fold increase in G protein subunit rel-
ative to the concentrations necessary to detect Gaq-promoted
increases in enzyme activity. At equimolar PLC enzyme con-
centrations, PLC-bX required a higher concentration of Gbg for
stimulation than PLC-b2 and PLC-bT, but less than PLC-b1
(Fig. 4B). For each PLC-b isoenzyme tested, Gbg was less effi-
cacious than Gaq for stimulation of PLC-b catalytic activity.
Lack of Regulation of PLC-bX by Gai or Gao Subunits—
Based on the contention that PLC-bX functions as the effector
enzyme in the PTX-sensitive inositol lipid signaling pathway of
Xenopus oocytes (18), we determined the capacity of recombi-
nant Gao, Gai1, Gai2, and Gai3 to activate PLC-bX in a recon-
stitution assay. None of these PTX-substrate a-subunits stim-
ulated PLC-bX activity at concentrations of a-subunit up to 30
nM and with concentrations of PLC-bX as high as 100 ng/assay.
This lack of activity was observed irrespective of whether AlF4
2
or preincubation with 1 mM GTPgS was utilized for G protein
activation (Fig. 5A).
To verify that purified recombinant Gao, Gai1, Gai2, and Gai3
were fully functional under our assay conditions, the ability of
these G protein a-subunits to attenuate Gbg-stimulated PLC
activity was tested. Gai and Gao subunits have been shown
previously to bind to Gbg in the absence of GTPgS and to inhibit
Gbg-subunit-promoted activation of PLC-bT (28). The capacity
of 3 nM Gbg to activate PLC-bT was attenuated by a 10-fold
molar excess of Gao, Gai1, Gai2, or Gai3 subunit (Fig. 5B).
Under these same assay conditions Gao, Gai1, Gai2, and Gai3
were ineffective as activators of PLC-bX.
DISCUSSION
Baculovirus-promoted expression of PLC-bX has provided a
means to obtain this isoenzyme in purified form for the first
time and to examine directly its regulation by G protein sub-
units. We previously have applied this approach to generate
large amounts of purified PLC-b1, PLC-b2, and PLC-bT (23,
29). These three recombinant PLC-b isoenzymes exhibit phys-
ical, catalytic, and regulatory properties that are indistinguish-
able from their native counterparts. Thus, there is strong rea-
son to expect that recombinant PLC-bX exhibits properties
that reflect with high fidelity those of the native form of this
isoenzyme. Purified PLC-bX exhibited a Ca21 sensitivity and
phospholipid substrate specificity that were very similar to
those observed with other PLC-b isoenzymes. The apparent Km
of PLC-bX against PtdIns(4,5)P2 also was similar to that pre-
viously observed for recombinant PLC-b1 and PLC-b2 (29), and
the Vmax of the recombinant Xenopus isoenzyme was as high as
any reported to date for PLC isoenzymes.
The relatively high sequence homology between PLC-bX and
the other PLC-b isoenzymes cloned to date suggests that the
overall in vivo function of the Xenopus isoenzyme is likely
similar to the signaling activity of the previously characterized
mammalian and avian isoenzymes. Thus, it is not surprising
that the PLC-bX isoenzyme was activated both by G protein
FIG. 3. Comparative activation of PLC-bX by Gaq. The indicated
amounts of PLC-bX enzyme (A) or 3 ng of the indicated PLC-b isoen-
zyme (B) were incubated with the indicated concentrations of purified
Gaq subunit activated with AlF4
2 in a reconstitution assay for 5 min at
30 °C. PLC activity was quantitated as described under “Experimental
Procedures.” The results are representative of two (A) or three (B)
similar experiments.
FIG. 4. Comparative activation of PLC-bX by Gbg. The indicated
amounts of PLC-bX enzyme (A) or 30 ng of the indicated PLC-b isoen-
zyme (B) were incubated with the indicated concentrations of recombi-
nant Gb1g2 in a reconstitution assay for 5 min at 30 °C. PLC activity was
quantitated as described under “Experimental Procedures.” The results
are representative of three similar experiments repeated with purified
bovine brain Gbg and recombinant Gb1g2.
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a-subunits of the Gq class of G proteins and by Gbg. In both
cases stimulation of PLC-bX required higher concentrations of
G protein subunits than some of the other PLC-b isoenzymes.
Although not studied here, PLC-b3, which has the highest
percent identity to the Xenopus isoenzyme, previously was
shown to be activated by both G protein subunits of the Gaq
class and by Gbg (19). The physiological significance of activa-
tion of PLC-b isoenzymes by Gbg is not unequivocally known,
but widespread acceptance exists for the concept that certain
mammalian PLC-b isoenzymes are activated as a consequence
of release of Gbg from PTX-sensitive G proteins.
The results of Iyengar and co-workers using injection of
purified Ga proteins or antisense mRNA (4, 10, 13, 18) suggest
that Gao is prominently involved in pertussis toxin-sensitive
activation of the inositol lipid signaling pathway of Xenopus
oocytes by several G protein-linked receptors. Other laborato-
ries have implicated Gai (3, 11, 14, 15) in this signaling path-
way in Xenopus oocytes. Thus, the observation of Ma et al. (18)
that antisense-promoted inhibition of expression of PLC-bX
results in a concurrent loss of pertussis toxin-sensitive, G pro-
tein-coupled receptor-stimulated, ICa-Cl not only implicated this
isoenzyme in the receptor-regulated pathway in oocytes but led
to the suggestion that PLC-bX may exhibit a novel activating
response to Gao and/or Gai. The results reported here are
inconsistent with the proposed activating role for a-subunits in
a PTX-sensitive pathway involving PLC-bX in Xenopus oo-
cytes. Neither Gao nor any of the Gai isoforms activated
PLC-bX under conditions in which these proteins were shown
to interact effectively with Gbg. Thus, PLC-bX is not directly
regulated by a-subunits of the PTX-sensitive class of G pro-
teins. Although it could be argued that Xenopus G protein
a-subunits may exhibit functional activities distinct from the
mammalian counterparts used in the current study, this is
unlikely based on the 90% homology between mammalian and
frog G proteins and the lack of any evidence for differences in
the physiological activity of species homologues of G protein
subunits.
Iyengar and co-workers (18) have reported that Gbg is not
involved in the PTX-sensitive inositol lipid signaling response
of Xenopus oocytes. However, Stehno-Bittel et al. (5) recently
reported conflicting results showing that Gbg promoted activa-
tion of ICa-Cl in oocytes and suggested that Gbg released from Gq
family heterotrimers mediate PTX-insensitive activation of the
inositol lipid signaling pathway. Since PLC-bX is activated by
Gbg, this isoenzyme could function as the effector protein in
such a pathway. PLC-bX clearly was more sensitive to activa-
tion by Gaq than by Gbg under our assay conditions. In fact, all
purified PLC-b isoenzymes characterized to date are more sen-
sitive to activation by Gaq than Gbg in vitro in spite of in vivo
evidence suggesting that PLC-b2 is primarily stimulated by
Gbg. However, comparison of the relative sensitivity to activa-
tion of PLC-b isoenzymes in vitromay not be entirely reflective
of activation in vivo, since in vitro studies have routinely em-
ployed AlF4
2 or GTPgS for a-subunit activation rather than the
native GTP activator. PLC-b isoenzymes impart substantial
GTPase activity to Gaq class subunits (30, 31) and may apear
more potently stimulated by AlF4
2-bound Ga than by natural
GTP-activated Ga. Complete insight into the relative activa-
tion of PLC-b isoenzymes by G protein subunits awaits the
characterization in progress of the relative GTPase activities of
PLC-b isoenzymes as well as identification of other factors that
may impinge on PLC-b activity in vivo.
In summary, we have purified PLC-bX and have examined
its relative activation by G protein subunits in vitro. Contrary
to suggestions from previous work on inositol lipid signaling in
Xenopus oocytes, this PLC-b isoenzyme is not activated by G
protein subunits that are PTX substrates. Instead PLC-bX
appears to be regulated similarly to other PLC-b isoenzymes
(recombinant or native) purified thus far. Our data on PLC-bX,
together with those of Ma et al. (18) on inhibition of signaling in
oocytes by antisense oligonucleotides based on the PLC-bX
coding sequence, make important a clear resolution of the
effects of Gbg on inositol lipid signaling in this model system.
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